212Pb-PSV40X

N/A

Report date: 2025/11/20 16:04:41

Base Information

Drug Name212Pb-PSV40X
Drug Alias NameN/A
ClassificationRadiation-emitting products > Nuclides > Lead > 212PbRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Radionuclide Drug Conjugates +[4] 
Mechanisms of ActionProstate-Specific Membrane Antigen binders
TargetsProstate-Specific Membrane Antigen
Therapy Area/IndicationsProstatic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPerspective Therapeutics IncMayo Clinic
China Registration ClassN/A

Develop Information

Active CompaniesPerspective Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsProstatic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A